HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid carvedilol up-titration in hospitalized patients with systolic heart failure.

Abstract
To determine whether carvedilol can be safely up-titrated before hospital discharge, we studied 372 consecutive patients with systolic heart failure who were being treated with carvedilol. Carvedilol was initiated a median of 3 days after admission, with a mean starting dose of 12 mg. Up-titration was performed in 67% of patients, with a mean increase of 16 mg and a mean discharge daily dose of 23 +/- 17 mg. Mean daily dose at the end of follow-up was 35.3 +/- 25.3 mg and it increased with higher discharge dose.
AuthorsManuel Martínez-Sellés, Tomás Datino, Marta Alhama, Nelida Barrueco, Isabel Castillo, Francisco Fernández-Avilés
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 27 Issue 8 Pg. 914-6 (Aug 2008) ISSN: 1557-3117 [Electronic] United States
PMID18656807 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbazoles
  • Propanolamines
  • Vasodilator Agents
  • Carvedilol
Topics
  • Aged
  • Carbazoles (therapeutic use)
  • Carvedilol
  • Dose-Response Relationship, Drug
  • Female
  • Heart Failure, Systolic (drug therapy)
  • Humans
  • Inpatients
  • Male
  • Middle Aged
  • Propanolamines (therapeutic use)
  • Retrospective Studies
  • Time Factors
  • Titrimetry
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: